STOCK TITAN

February 2024 Stock Gainers on News, Micro Caps Included

Ranked by the close-to-close change of the trading session each announcement landed in. How this is measured.

Data as of the trading session of , 20 of 20 completed market sessions produced ranked moves. That date is the last ranked session, not the last priced one, so follow-through dates run later.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

See the biggest losers of February 2024

100

Ranked gains

+1092.05%

Largest, HOLO

92.0%

Above baseline, day +5

8.5%

Median give-back, day +5

Filter and sort
Rows

100 ranked gains in February 2024

Skip the ranked rows and go to the month summary

Every percentage on a row, the follow-through readings included, is measured against that row's own pre-news close, which the row names. A day +5 reading is therefore the move from before the announcement, not a further change on top of the headline percentage.

Rank Symbol close to close Session Catalyst Announcement
1 HOLO +1092.05% against the close of 2024-02-06 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement MicroCloud Hologram Planned to Join the Communications Industry Association

05:20 ET premarket

2 BMR under $25M today More than one ranked move this month 2+ ranked moves +371.56% against the close of 2024-02-09 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Beamr and NVIDIA team up to accelerate adoption of the newest video standard - AV1

07:00 ET premarket

3 GRYP under $25M today Also on the opposite board this month on both boards +354.62% against the close of 2024-02-08 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Crypto & Treasury Gryphon Digital Mining Debuts on Nasdaq

09:28 ET premarket

4 VANI +270.30% against the close of 2024-02-27 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic®/Wegovy® and Discloses NPM-139 as Semaglutide as Strategy Shifts to Prioritize Obesity Portfolio

08:30 ET premarket

5 JANX +229.47% against the close of 2024-02-26 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Janux Announces Encouraging Safety and Efficacy Data in Ongoing Dose Escalation Trials for PSMAxCD3-TRACTr JANX007 in mCRPC and EGFRxCD3-TRACTr JANX008 in Solid Tumors

16:05 ET after hours

6 GXAI under $25M today +177.18% against the close of 2024-02-15 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Gaxos Gaming to Launch AI Solution for Game Developers and Studios

08:30 ET premarket

7 INBS under $25M today More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards +146.89% against the close of 2024-02-01 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Second Quarter and Six-Month Revenue Results

08:30 ET premarket

8 INBS under $25M today More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards +134.90% against the close of 2024-02-08 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Intelligent Bio Solutions Inc. Reports Fiscal Second Quarter and Six-Month Financial Results and Operational Highlights

08:30 ET premarket

9 SCTL +132.61% against the close of 2024-02-28 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Societal CDMO Enters Into Definitive Agreement to be Acquired by CoreRx, Inc.

16:29 ET after hours

10 VKTX +121.02% against the close of 2024-02-26 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Viking Therapeutics Announces Positive Top-Line Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in Patients with Obesity

07:03 ET premarket

11 ENGN +116.54% against the close of 2024-02-13 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution enGene Announces Oversubscribed $200 Million Private Placement Financing

06:50 ET premarket

12 GLT +106.25% against the close of 2024-02-06 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Berry Global and Glatfelter Announce Plans for Tax-Free Spin-Off and Merger of Berry’s Health, Hygiene and Specialties Global Nonwovens and Films Business with Glatfelter, Creating a Global Specialty Materials Leader

07:00 ET premarket

13 AKLI +104.11% against the close of 2024-02-23 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in Japan

08:47 ET premarket

14 NSTG Also on the opposite board this month on both boards +97.93% against the close of 2024-02-08 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement NanoString Announces Completion of Financing to Support Restructuring Process

06:30 ET premarket

15 MNPR More than one ranked move this month 2+ ranked moves +96.49% against the close of 2024-02-21 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers

07:00 ET premarket

16 GRRR +96.36% against the close of 2024-02-02 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Gorilla Technology Group Reports Results Through Third Quarter 2023

08:00 ET premarket

17 VTVT +95.88% against the close of 2024-02-27 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution vTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D Fund

08:00 ET premarket

18 MNPR More than one ranked move this month 2+ ranked moves +95.27% against the close of 2024-02-16 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101-Zr in Advanced Cancers

08:00 ET premarket

19 HTOO under $25M today +90.00% against the close of 2024-02-15 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Fusion Fuel Receives Notification of IPCEI Approval from European Commission for 630 MW HEVO-Portugal Project

04:00 ET premarket

20 FBLG under $25M today Also on the opposite board this month on both boards +88.38% against the close of 2024-02-12 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results FibroBiologics Presents Preclinical Data at the 2024 Keystone Symposia for Systemic Autoimmune and Autoinflammatory Diseases

09:31 ET intraday

21 ADIL under $25M today +85.50% against the close of 2024-02-27 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office

09:30 ET intraday

22 FDMT +84.62% against the close of 2024-02-02 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results 4DMT Presents Positive Interim Data from Randomized Phase 2 PRISM Clinical Trial of Intravitreal 4D-150 Demonstrating Favorable Tolerability & Clinical Activity in Wet AMD

17:00 ET after hours

23 PLCE Also on the opposite board this month release reads negative on both boards +81.12% against the close of 2024-02-14 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Release reads negative, stock rose 81.12% The Children’s Place Provides Shareholder Update

06:30 ET premarket

24 BOF +80.06% against the close of 2024-02-09 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement BranchOut Food Expands Relationship with Nation’s Largest Retailer, Valued at an estimated $7.6M Annually

08:00 ET premarket

25 EBS +78.29% against the close of 2024-02-20 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO

07:00 ET premarket

26 ENVB under $25M today +74.49% against the close of 2024-02-28 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of Three Classes of Compounds

07:00 ET premarket

27 TELO +69.76% against the close of 2024-02-13 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Uplisting / Compliance Telomir Pharmaceuticals Announces Closing of Initial Public Offering

16:05 ET after hours

28 AXTI +69.30% against the close of 2024-02-22 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings AXT, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results

16:05 ET after hours

29 NRBO under $25M today +67.28% against the close of 2024-01-31 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory NeuroBo Pharmaceuticals Announces FDA Clearance of IND for a Phase 1 Clinical Trial of DA-1726 for the Treatment of Obesity

08:01 ET premarket

30 MSAI under $25M today +65.57% against the close of 2024-02-14 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement MultiSensor AI Unveils SmartIR 2.0 Software Platform

14:05 ET intraday

31 SEED under $25M today +64.34% against the close of 2024-02-20 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Origin Agritech Grows Revenue by 77% Year-Over-Year, Records Net Income of $8.7 Million

07:00 ET premarket

32 MRVI +63.60% against the close of 2024-02-22 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results

16:05 ET after hours

33 COGT +59.34% against the close of 2024-02-13 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Cogent Biosciences Announces Oversubscribed $225 Million Private Placement

07:00 ET premarket

34 BZFD +58.10% against the close of 2024-02-21 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition BuzzFeed, Inc. Announces Sale of Complex to NTWRK in All-Cash Deal

16:05 ET after hours

35 FHTX +55.45% against the close of 2024-02-07 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Foghorn Provides Pipeline Update on FHD-909 BRM Selective Inhibitor

07:00 ET premarket

36 ZENV under $25M today +54.78% against the close of 2024-02-05 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Zenvia Announces Agreements to Address Funding Gap and Introduces EBITDA Guidance for 2024

09:15 ET premarket

37 KPRX under $25M today +53.87% against the close of 2024-01-31 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Kiora Pharmaceuticals and Théa Open Innovation Enter Strategic Agreement to Develop and Commercialize KIO-301 for the Treatment of Inherited Retinal Diseases; Total Deal Value of up to $301 Million includes $16 Million Upfront, up to $285 Million in Clinical Development, Regulatory and Commercial Milestones, Plus Commercial Royalties

17:15 ET after hours

38 SOGP +53.74% against the close of 2024-02-20 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Sound Group Embraces Generative AI to Unveil New AI-Powered Applications

06:30 ET premarket

39 BFRI under $25M today +53.44% against the close of 2024-02-16 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Biofrontera Inc. Announces Private Placement of Up To $16.0 Million Priced at Market per Nasdaq Rules

08:05 ET premarket

40 ROOT +53.29% against the close of 2024-02-21 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Root, Inc. Announces 2023 Fourth Quarter and Full Year Results

16:15 ET after hours

41 BAND +51.77% against the close of 2024-02-27 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Bandwidth Announces Fourth Quarter and Full Year 2023 Financial Results, Exceeding Revenue and Profitability Guidance

07:00 ET premarket

42 CNVS Also on the opposite board this month on both boards +51.61% against the close of 2024-02-13 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Cineverse Partners with Google Cloud to Launch a Conversational AI-Powered Search & Discovery Tool for Film and Television Content

09:00 ET premarket

43 ARM +47.89% against the close of 2024-02-07 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Arm Holdings plc Reports Results for the Third Quarter of the Financial Year Ending 2024

16:02 ET after hours

44 CISO under $25M today +47.00% against the close of 2024-02-16 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement CISO GLOBAL RECEIVES VALUATION OF MORE THAN $50 MILLION FOR INITIAL SUITE OF IP SOLUTIONS

08:30 ET premarket

45 MIRA +45.99% against the close of 2024-02-02 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement MIRA Pharmaceuticals Provides Corporate Update

08:30 ET premarket

46 UCAR under $25M today Also on the opposite board this month on both boards +45.52% against the close of 2024-02-07 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change U Power Announces Appointment of New Independent Director

05:00 ET premarket

47 BLZE +45.15% against the close of 2024-02-15 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Backblaze Announces Fourth Quarter and Full Year 2023 Financial Results

16:05 ET after hours

48 MATV +42.69% against the close of 2024-02-21 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Mativ Announces Fourth Quarter and Full Year 2023 Results

16:40 ET after hours

49 CRDL +42.31% against the close of 2024-02-14 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Cardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis

07:27 ET premarket

50 ONMD +42.23% against the close of 2024-02-28 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership OneMedNet Signs New Network Partnership Agreement with One of the Largest Private Hospital Operators in U.S.

08:00 ET premarket

51 EFSH under $25M today More than one ranked move this month 2+ ranked moves +42.05% against the close of 2024-02-09 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings 1847 Holdings Announces Positive Restatement of Financial Results for Subsidiary and Reduction in Loss from Operations of Approximately $3.6 Million and Increase in Assets of $642,000 for 2022

07:30 ET premarket

52 BMR under $25M today More than one ranked move this month 2+ ranked moves +41.31% against the close of 2024-02-12 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Beamr Imaging Ltd. Announces Pricing of $12 Million Public Offering

20:02 ET after hours

53 EFSH under $25M today More than one ranked move this month 2+ ranked moves +41.30% against the close of 2024-02-08 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution 1847 Holdings LLC Announces Pricing of $5.0 Million Public Offering

09:20 ET premarket

54 JMIA +41.18% against the close of 2024-02-14 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Jumia Reports Fourth Quarter and Full Year 2023 Results

08:00 ET premarket

55 KRYS +41.02% against the close of 2024-02-23 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Krystal Biotech Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates

08:00 ET premarket

56 ACMR +40.80% against the close of 2024-02-27 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings ACM Research Reports Fourth Quarter and Fiscal Year 2023 Results

05:00 ET premarket

57 SGMO +40.15% against the close of 2024-02-09 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Sangamo Therapeutics Announces U.S. FDA Alignment on Abbreviated Pathway to Potential Approval and EMA Prime Eligibility for ST-920 in Fabry Disease

08:05 ET premarket

58 APLT under $25M today More than one ranked move this month 2+ ranked moves +39.93% against the close of 2024-02-14 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Applied Therapeutics Announces Positive Results from 12-month Interim Analysis of Govorestat (AT-007) in the Ongoing INSPIRE Phase 3 Trial in Sorbitol Dehydrogenase (SORD) Deficiency

07:00 ET premarket

59 TAOP under $25M today +39.81% against the close of 2024-02-06 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Taoping Reports Record 78% Year-Over-Year Contract Revenue Growth for January

08:50 ET premarket

60 MODD +39.44% against the close of 2024-02-15 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Modular Medical Announces Proposed Public Offering

16:15 ET after hours

61 LASE +39.42% against the close of 2024-02-28 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Laser Photonics Scores Order from Pima Air & Space Museum for Its CleanTech Laser Cleaning System

07:00 ET premarket

62 WISH +39.11% against the close of 2024-02-09 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition ContextLogic Announces Agreement to Sell Substantially All Operating Assets and Liabilities Associated with Wish to Qoo10 for $173 Million in Cash

08:00 ET premarket

63 BRLS +38.90% against the close of 2024-02-06 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Reverse Merger / Shell Borealis Foods Inc., a Rapidly Growing, Mission-Driven Food Tech Company, Completes Business Combination and Will Commence Trading on Nasdaq Under the Symbol "BRLS"

13:41 ET intraday

64 GTHX Also on the opposite board this month on both boards +38.75% against the close of 2024-02-27 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings G1 Therapeutics Provides Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights

06:30 ET premarket

65 VLCN +38.68% against the close of 2024-02-27 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change Business Update from John Kim New CEO at Volcon Inc

07:30 ET premarket

66 DNLI +38.25% against the close of 2024-02-26 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Denali Therapeutics Announces $500 million Private Placement Equity Financing

08:00 ET premarket

67 MICS under $25M today +38.08% against the close of 2024-02-26 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Company Generates Record Subscriptions Sales for 2023 Holiday Season

07:00 ET premarket

68 LRMR +36.84% against the close of 2024-02-13 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Larimar Therapeutics Announces Proposed Underwritten Public Offering

16:18 ET after hours

69 SNAL +36.36% against the close of 2024-02-26 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Snail’s Innovates Development Pipeline with AI Technology

08:00 ET premarket

70 CTMX +36.36% against the close of 2024-02-26 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement CytomX Therapeutics to Present at Upcoming March Investor Conferences

08:00 ET premarket

71 UMAC +36.34% against the close of 2024-02-22 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Unusual Machines Completes Acquisitions of Fat Shark and Rotor Riot

16:01 ET after hours

72 VGAS +36.07% against the close of 2024-02-12 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Verde Clean Fuels, Inc. and Cottonmouth Ventures LLC Announce Joint Development Agreement for a Proposed Natural Gas-to-Gasoline Facility in Permian Basin

07:30 ET premarket

73 BMR under $25M today More than one ranked move this month 2+ ranked moves +35.70% against the close of 2024-02-15 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Beamr Imaging Ltd. Announces Closing of Public Offering and Full Exercise of Underwriter’s Option to Purchase Additional Shares

16:15 ET after hours

74 PEGA +35.67% against the close of 2024-02-14 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Pega Delivers Double-Digit ACV Growth and Record Cash Flow in Q4 2023

16:05 ET after hours

75 AHG +35.67% against the close of 2024-01-31 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition AHG Announces Plan to Acquire Online Clinic

16:00 ET after hours

76 IINN under $25M today +35.42% against the close of 2024-02-13 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Inspira™ Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System

07:30 ET premarket

77 FREE +35.33% against the close of 2024-02-12 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Whole Earth Brands Signs Definitive Agreement to be Acquired by Affiliates of Sababa Holdings FREE, LLC

08:00 ET premarket

78 LYFT +35.12% against the close of 2024-02-13 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Lyft Announces Fourth Quarter and Full-Year 2023 Results

16:05 ET after hours

79 DOOR +35.09% against the close of 2024-02-08 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Owens Corning Announces $3.9 Billion Acquisition of Masonite to Strengthen Position in Building and Construction Materials

07:05 ET premarket

80 LUNR +34.54% against the close of 2024-02-14 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement IM-1 Mission Nova-C Lunar Lander Successfully Enroute to the Moon Following its Launch on SpaceX’s Falcon 9

09:09 ET premarket

81 AREN +34.53% against the close of 2024-02-14 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Manoj Bhargava Invests $12 Million More in The Arena Group

18:25 ET after hours

82 ADVM Also on the opposite board this month release reads negative on both boards +34.51% against the close of 2024-02-02 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Release reads negative, stock rose 34.51% Adverum Biotechnologies Announces $127.5 Million Private Placement Financing

07:45 ET premarket

83 CFLT +34.09% against the close of 2024-02-07 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Confluent Announces Fourth Quarter and Fiscal Year 2023 Financial Results

16:03 ET after hours

84 PYXS +33.26% against the close of 2024-02-26 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Pyxis Oncology Announces $50 Million Private Placement

08:00 ET premarket

85 ATRA +33.10% against the close of 2024-01-31 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Atara Biotherapeutics and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel® Data in The Lancet Oncology

18:30 ET after hours

86 PRLD +33.05% against the close of 2024-02-15 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Prelude Therapeutics Reports Full Year 2023 Financial Results and Outlines Key Objectives for 2024

16:05 ET after hours

87 SMCI +32.87% against the close of 2024-02-21 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Supermicro Announces Proposed Offering of $1.5 Billion of Convertible Senior Notes Due 2029

17:09 ET after hours

88 CLSK +32.86% against the close of 2024-02-08 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings CleanSpark Reports First Quarter FY2024 Financial Results

16:00 ET after hours

89 WGS +32.63% against the close of 2024-02-20 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024

16:26 ET after hours

90 APLT under $25M today More than one ranked move this month 2+ ranked moves +32.62% against the close of 2024-02-27 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Applied Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the Treatment of Classic Galactosemia

08:00 ET premarket

91 TELL +32.57% against the close of 2024-02-05 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Tellurian Explores Sale of Haynesville Upstream Assets

07:00 ET premarket

92 BRTX under $25M today Also on the opposite board this month on both boards +32.52% against the close of 2024-01-31 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results BioRestorative Therapies to Present Preliminary BRTX-100 Clinical Data at the Orthopaedic Research Society (ORS) 2024 Annual Meeting

07:30 ET premarket

93 WATT +32.30% against the close of 2024-02-14 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement WiGL and Energous Announce Developmental Milestone to Bring Touchless Wireless Power Transfer Networks to Market

09:30 ET intraday

94 VERX release reads negative +32.20% against the close of 2024-02-28 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Release reads negative, stock rose 32.20% Vertex Announces Fourth Quarter and Full Year 2023 Financial Results

07:00 ET premarket

95 BLNK +32.09% against the close of 2024-02-13 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement BLINK CHARGING ANNOUNCES PRELIMINARY FULL-YEAR 2023 REVENUE IN EXCESS OF $140 MILLION, REITERATES ADJUSTED EBITDA PROFITABILITY TARGET

07:45 ET premarket

96 CVNA +32.09% against the close of 2024-02-22 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Carvana Announces Record Fourth Quarter and Full Year 2023 Results

16:10 ET after hours

97 IOVA +31.48% against the close of 2024-02-16 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Iovance Biotherapeutics, Inc. Announces Pricing of $211 Million Underwritten Offering of Common Stock

06:30 ET premarket

98 MNY +31.43% against the close of 2024-02-08 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change MoneyHero Group Announces Resignation of Chief Financial Officer

16:30 ET after hours

99 TENX Also on the opposite board this month on both boards +31.31% against the close of 2024-02-05 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Tenax Therapeutics Announces USPTO Grants Notice of Allowance for U.S. Patent Application, Significantly Broadening IP Protection for Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

08:30 ET premarket

100 AHCO +31.06% against the close of 2024-02-26 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook

07:00 ET premarket

NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today. 268 events never entered this month's eligible pool, because the ticker is a warrant, a unit, a right or a preferred rather than common stock, or carries a stored capitalization above $10 trillion, which is larger than any company has reached. Exclude the $5M to $25M band

4 candidate events for this board could not be anchored to a trading session and are not listed.

1 event was left out of this board because the stored move and the session's own closing prices disagree by far more than a measurement difference, so neither figure could be published.

3 events were left out of this board because the vendor names the ticker as a preferred, a note, a depositary share or a fund rather than a company's common stock.

1 event was left out of this board because the measured session set no price of its own, trading either nothing at all or barely moving on an ordinary day's volume, so the figure it would be ranked on is a price carried onto the tape rather than a close.

1 event was left out of this board because the ticker had not traded for more than 10 days before the measured session, so no comparable prior close exists.

Company names are not shown on months older than a year, because only the current holder of each ticker is known.

In February 2024, the median gainer had given back 8.5% of its move five sessions later; the largest catalyst group was Other Announcement, 28 of the 100 events, at a median of +54.3%.

Close-to-close change on the measured trading session, against the previous close.

NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.

Which catalysts drove the board

Swipe the table sideways for the day +5 columns.

Catalyst Events Share of board Median move close to close Median at day +5 Still above the pre-news close at day +5
Other Announcement 28 28.0% +54.3% +57.4% 92.9% of 28
Earnings 24 24.0% +41.1% +47.4% 100.0% of 24
Offering / Dilution 14 14.0% +38.8% +36.0% 92.9% of 14
Clinical Trial Results 12 12.0% +86.5% +57.5% 91.7% of 12
M&A / Acquisition 8 8.0% Fewer than 10 events in this group, so no figures are shown.

6 other catalyst types, 14 events: Contract / Partnership, Leadership Change, FDA & Regulatory, Reverse Merger / Shell, Uplisting / Compliance, Crypto & Treasury.

How much of the move survived

Horizon Still above the pre-news close close to close Median change since the measured close as a share of the move
Day +1 99.0% of 100 0.2% given back, of 100
Day +5 92.0% of 100 8.5% given back, of 100
Month end 92.6% of 95 15.4% given back, of 95
Month end falls before day +5 for 22 of these 95 events, so this row is not a later horizon than the one above it. 95 of the 100 events have a month-end close later than the measured session; 5 have it on the measured session itself.

Both figures in a row are measured over the events that have a close at that horizon, the count printed beside each of them, not over all 100 events on this board, which is why the denominators differ between rows.

Repeat runners

Some companies move on news more than once. The left list holds the ones that moved twice or more this month; the right list holds the ones that also moved in the months before it. The ranking above shows one row per move, so a name that keeps coming back is only visible here.

Moved twice or more inside February 2024

Two or more ranked moves this month, each on a different trading day.

SymbolMeasured sessionsBest move
BMR 3Other Announcement, Offering / Dilution +371.56%
INBS 2Earnings +146.89%
MNPR 2Clinical Trial Results +96.49%
EFSH 2Earnings, Offering / Dilution +42.05%
APLT 2Clinical Trial Results, FDA & Regulatory +39.93%

Also risen on news in earlier months

Ranked in at least two of the three months before this one. They are listed whether or not they rank this month, which is why the months are named.

SymbolMonthsBest move
GETR 2024-01, 2023-12 +84.85%
SIDU 2024-01, 2023-12 +163.16%
DATS 2024-01, 2023-12 +58.25%
CYN 2024-01, 2023-12 +64.00%
SHOT 2024-01, 2023-11 +34.91%
GNS 2024-01, 2023-12 +28.77%
SNES 2024-01, 2023-12 +34.38%
AXGN 2024-01, 2023-11 +36.90%
CDIO 2024-01, 2023-11 +123.23%
SLDB 2023-12, 2023-11 +68.42%
PAPL 2023-12, 2023-11 +50.68%
INBSthis month too 2023-12, 2023-11 +92.51%

What the board was made of

Price before the move

Price bands are not shown on months older than a year, because the stored prices are adjusted for splits done since and a company that has reverse-split lands in a band its shares never traded in.

When the announcement landed

  • Pre-market66.0%
  • Intraday5.0%
  • After hours29.0%

Volume against normal

  • Under 5x9 events, 9.3%
  • 5x to 20x34 events, 35.1%
  • Over 20x54 events, 55.7%

3 events have too little trading history for a relative volume, and are not in the tiers above.

Industry

  • Pharmaceutical Preparations25 events, 25.0%
  • Biological Products, (no Diagnostic Substances)7 events, 7.0%
  • Services-prepackaged Software6 events, 6.0%
  • Surgical & Medical Instruments & Apparatus4 events, 4.0%
  • Services-management Consulting Services3 events, 3.0%
  • Finance Services2 events, 2.0%

31 other industries, 35 events

Industry not known: 18.0%

3 events on this board carry the flag for a move that ran against its own release, too few to say whether the flag predicts anything.

Against January 2024

100 events in the comparable window.

January 2024 median +31.1%, selected from the 8,863 events in that month's eligible pool

February 2024 median +42.1%, 11.0 points above January 2024. February 2024's median is taken over the 100 ranked rows, selected from the 10,433 events in that month's eligible pool.

How this ranking is measured

Close-to-close change on the measured trading session, against the previous close.

  • An announcement before 16:00 ET is measured on that trading day; one at or after 16:00 ET, or on a weekend, is measured on the next trading day.
  • One row per company and measured session. Other announcements the company made in the same session are listed inside the row.
  • A ranking is a coincidence of news and price on the same session, not proof that the news caused the move. Part of an intraday move can precede the announcement.
  • No Stated Cause marks a release in which the company itself says it knows of no reason for the move, while Other Announcement marks a release these rules could not classify.

Eligibility uses each company's capitalization today, not its capitalization at the time. Archive boards can therefore change as companies grow or shrink.

Prices are adjusted for stock splits the company has done since, so an older row's dollar figures are stated on today's share count and are not the prices that traded that day. The percentage move, the dollar volume and the relative volume are unaffected, because both prices carry the same adjustment. The session's share count carries the adjustment too, so the shares figure beside the dollar volume is that count restated on today's basis rather than the number of shares that changed hands. Where the ticker was retired the price series stops with it and no later adjustment reached it, so those rows are marked as traded and their dollars are the ones that changed hands on the day.

Market cap is not shown on months older than a year, because only today's figure exists.

NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

This archive starts at 2020-04, the first month with ranked moves.